with the Karolinska
Institute in Stockholm, Sweden, a pilot clinical trial with the HER2 DNA
vaccine has been conducted in patients with Stage IV breast cancer and has
demonstrated safety. Further testing is being considered.
Dr. Wei added, "As we continue our extensive research on this promising
vaccine, based on the results to-date, we believe this could eventually
help control the spread of HER2-positive breast cancer in patients who have
been resistant to other treatments, and possibly prevent HER2-positive
breast cancer from occurring."
Other researchers working with Dr. Wei include: Paula J. Whittington,
Marie P. Piechocki, Henry H. Heng, Jennifer B. Jacob, Richard F. Jones and
Jessica B. Back.
Located in mid-town Detroit, MI, the Barbara Ann Karmanos Cancer
Institute is one of 41 National Cancer Institute-designated comprehensive
cancer centers in the United States. Caring for more than 6,000 new
patients annually on a budget of $216 million, conducting more than 700
cancer-specific scientific investigation programs and clinical trials, the
Karmanos Cancer Institute is among the nation's best cancer centers.
Through the commitment of 1,000 staff, including nearly 300 faculty
members, and supported by thousands of volunteer and financial donors, the
Institute strives to prevent, detect and eradicate all forms of cancer.
John C. Ruckdeschel, M.D., is the Institute's president and chief executive
officer. For more information call 1-800-KARMANOS or go to
Page: 1 2 Related medicine technology :1
|SOURCE Barbara Ann Karmanos Cancer Institute|
Copyright©2008 PR Newswire.
All rights reserved
. Carrington Subsidiary DelSite Initiates Critical Toxicology Studies of Its Nasal Powder Bird Flu Vaccine2
. Iomai Trial Shows 100 Percent Immune Response in Elderly Subjects Vaccinated With Novel Travelers Diarrhea Patch Vaccine3
. GlaxoSmithKline Receives New HHS Order for H5N1 Bulk Antigen. First North American Clinical Trials with GSKs Candidate Pre-pandemic Flu Vaccine to Start.4
. Intellect Neurosciences, Inc. to Present Data on Alzheimers Vaccine at 13th International Congress of Immunology Conference5
. Pre-clinical Data on Recent Advances with HIV VLP Vaccine Presented at AIDS Vaccine 07 Conference6
. Multiple NIH Phase 2 HIV Vaccine Trials Using Vicals Technology Produce Encouraging Results7
. Iomai Announces Data from Phase 2 Field Study of Travelers Diarrhea Vaccine Accepted for Presentation at ICAAC8
. Vical Begins Phase 1 Trial of DNA Vaccine Against H5N1 Pandemic Influenza9
. Iomai Launches Phase 1/2 Safety Study of Dose-Sparing Patch for Use With Pandemic Influenza Vaccine10
. Sinovac Commences Vaccination on Volunteers for Phase II Clinical Trial on Pandemic Influenza H5N1 Vaccine11
. GeoVax Successful HIV/AIDS Vaccine Trial Data Presented at AIDS Vaccine 2007 Conference